Coming out as a cancer survivor

Article

I had cancer. There. I said it.It's only three words, but telling friends or new acquaintances that I'm a cancer survivor can be difficult. Somehow the topic arises--usually because someone's family member has been affected by some type of cancer. My heart begins to beat wildly, but I can't stop myself from exercising my intense desire to share common experiences. So I say it.Eyebrows raise, eyes widen. I'm very familiar with this shocked and sometimes panicked expression. And then of course I have to explain.I explain that when I was only two years old I was diagnosed with leukemia, more specifically acute lymphoblastic leukemia, and that I was enrolled in a randomly selected drug trial. I explain that I almost died, but that I unexpectedly went into remission at age five. I also explain that my sister, who is five years my junior, went through the same thing, only less severe."I don't remember anything," I hurriedly say as a sort of reassurance. And it's true. I don't remember the countless injections or the spinal taps or the incessant hospitalizations. I've managed to piece together my experience with cancer thanks to verbal memories from my father and my memories of my sister's experience with the same disease. Although I regard my status as a cancer survivor like an invisible medal, a unique characteristic of mine, I often fail to realize that so many people tend to associate unfounded stigmas with cancer.I'll receive responses like, "Are you OK now?" or "Did your hair fall out?" or even "Are you still being treated for it?" Yes, yes and no, for the record.Sometimes I don't have the opportunity to explain, like at the dentist's office. A new dentist will see what I call my "mini tooth," which was stunted because of the chemotherapy. "I had cancer," I'll awkwardly and almost unintelligibly explain. Usually silence follows, and I'm unsure whether he or she understands.I don't want to be characterized as "the girl who had cancer" because there are so many other things that define me. I'm a daughter, a sister, a friend, a student, a cook, a writer, a music lover and so many other things. My status as a cancer survivor is a part of me, but it's certainly not the most important part of me.Yes, I had cancer. Now let's move on.Rachel Post is a 21-year-old, magazine journalism student at the University of Missouri-Columbia and a proud leukemia survivor.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content